Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2C | P28335 | 5/20 | 0.39 |
| ▸ | HTR2B | P41595 | 4/20 | 0.39 |
| ▸ | HTR2A | P28223 | 1/20 | 0.36 |
| ▸ | L3MBTL3 | Q96JM7 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | CXCR4 | P61073 | 6/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.33 |
| ▸ | MEN1 | O00255 | 2/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.33 |
| ▸ | HRH3 | Q9Y5N1 | 2/20 | 0.33 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.33 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.33 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.33 |
| ▸ | CCR2 | P41597 | 1/20 | 0.33 |
| ▸ | CXCL12 | P48061 | 1/20 | 0.33 |
| ▸ | BLM | P54132 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | PKM | P14618 | 1/20 | 0.32 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Oxirane SCHEMBL608361 | 0.68 | HTR6 (0.36) | HTR2CHTR2BHTR2A | |
| SCHEMBL8657726 | 0.67 | L3MBTL3 (0.44) | HTR2CHTR2BL3MBTL3L3MBTL1KMT2A | |
| SCHEMBL12469538 | 0.67 | HTR6 (0.54) | HTR2CHTR2BHTR2AL3MBTL3L3MBTL1 | |
| SCHEMBL13836186 | 0.67 | — | — | |
| SCHEMBL28838207 | 0.67 | L3MBTL3 (0.40) | HTR2CHTR2BHTR2AL3MBTL3L3MBTL1 | |
| SCHEMBL11639039 | 0.66 | HTR2C (0.58) | HTR2CHTR2BHTR2AKMT2AHPGD | |
| SCHEMBL51727 | 0.64 | HTR6 (0.54) | L3MBTL3L3MBTL1KMT2AHRH3HPGD | |
| SCHEMBL993907 | 0.64 | HTR6 (0.48) | HTR2CHTR2BHTR2AL3MBTL3L3MBTL1 | |
| SCHEMBL6395460 | 0.64 | HTR6 (0.54) | L3MBTL3L3MBTL1KMT2AHRH3HPGD | |
| SCHEMBL12730892 | 0.63 | HTR6 (0.54) | HTR2CHTR2BL3MBTL3L3MBTL1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2391211-A1 | METHODS AND COMPOSITIONS FOR TREATING BREAST CANCER | Genzyme Corporation (US) | 2011-12-07 | — | — | EP | claimed |
| EP-2384115-A1 | METHODS AND COMPOSITIONS FOR TREATING HEMATOLOGICAL MALIGNANCIES | Genzyme Corporation (US) | 2011-11-09 | — | — | EP | claimed |
| WO-2010088398-A1 | METHODS AND COMPOSITIONS FOR TREATING HEMATOLOGICAL MALIGNANCIES | GENZYME CORPORATION (US) | 2010-08-05 | — | — | WO | claimed |
| WO-2010088401-A1 | METHODS AND COMPOSITIONS FOR TREATING BREAST CANCER | GENZYME CORPORATION (US) | 2010-08-05 | — | — | WO | claimed |
| EP-2384115-A1 | METHODS AND COMPOSITIONS FOR TREATING HEMATOLOGICAL MALIGNANCIES | Genzyme Corporation (US) | 2011-11-09 | — | — | EP | disclosed |
| WO-2010088398-A1 | METHODS AND COMPOSITIONS FOR TREATING HEMATOLOGICAL MALIGNANCIES | GENZYME CORPORATION (US) | 2010-08-05 | — | — | WO | disclosed |
| WO-2010025416-A1 | CXCR4 ANTAGONISTS FOR KIDNEY INJURY | GENZYME CORPORATION (US) | 2010-03-04 | — | — | WO | disclosed |
| EP-2068868-A2 | COMBINATION THERAPY | Genzyme Corporation (US) | 2009-06-17 | — | — | EP | disclosed |
| EP-2056853-A1 | COMBINATION THERAPY | Genzyme Corporation (US) | 2009-05-13 | — | — | EP | disclosed |
| WO-2008019371-A1 | COMBINATION THERAPY | GENZYME CORPORATION (US) | 2008-02-14 | — | — | WO | disclosed |
| WO-2008017025-A2 | COMBINATION THERAPY | GENZYME CORPORATION (US) | 2008-02-07 | — | — | WO | disclosed |
| EP-1796716-A2 | CHEMOKINE COMBINATIONS TO MOBILIZE PROGENITOR/STEM CELLS | ANORMED INC. (CA) | 2007-06-20 | — | — | EP | disclosed |
| WO-2006020891-A2 | CHEMOKINE COMBINATIONS TO MOBILIZE PROGENITOR/STEM CELLS | ANORMED INC. (CA) | 2006-02-23 | — | — | WO | disclosed |